Accession Number: | 0001562180-20-005100 |
Date: | 2020-07-08 |
Issuer: | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. (BHVN) |
Original Submission Date: |
BERMAN ROBERT
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN, CT 06510
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON SHARES | 2020-07-08 | M | 58,404 | a | $0.61 | 58,745 | direct | ||
COMMON SHARES | 2020-07-08 | S | 55,626 | d | $75.25 | 3,119 | direct | ||
COMMON SHARES | 2020-07-08 | S | 2,778 | d | $75.29 | 341 | direct | ||
COMMON SHARES | 2020-07-08 | 0 | $0.00 | 550,000 | indirect | ||||
COMMON SHARES | 2020-07-08 | 0 | $0.00 | 240,500 | indirect | ||||
COMMON SHARES | 2020-07-08 | 0 | $0.00 | 50 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 0.61 | 2020-07-08 | deemed execution date | M | 58,404 (d) | 2024-11-25 | common shares 58,404 | $0.61 | 0 | direct |
ID | footnote |
---|---|
f1 | these exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the reporting person. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $75.00 - $75.95, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this form 4. |
f3 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $76.00 - $76.22, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this form 4. |
f4 | the option, representing a right to purchase a total of 225,000 shares, was granted on november 26, 2014, and vested in four equal installments on november 26, 2014, 2015, 2016 and 2017 |